SHENZHEN, China, April 22, 2026 /PRNewswire/ — The 57th World Earth Day is being observed on April 22, 2026, under a theme calling for the protection of natural resources. Weeks later, the 18th China International Battery Fair (CIBF2026), one of the world’s largest gatherings focused on battery technology and sustainable energy, is set to open from May 13 to 15 at the Shenzhen World Exhibition & Convention Center. Organized by the China Industrial Association of Power Sources (CIAPS) under the theme “Connecting the Globe, Empowering Green Energy and Driving the Future,” the 280,000-square meter event will draw over 3,100 exhibitors from China and abroad.

The Earth Day theme aligns with a broader push toward peak emissions and carbon neutrality, increasingly reflected in regulatory requirements, industrial standards, and procurement expectations across the supply chain. Much of this shift is now taking place at the industrial level, where battery manufacturing, energy storage, and recycling are moving toward lower-emission production and more circular resource use.

Regulatory activity around zero-carbon factories and battery recycling has picked up this year. In China, five central government departments jointly issued guidelines on January 14 to promote the construction of zero-carbon factories, identifying key sectors (lithium batteries among them) for pilot zero-carbon projects. Furthermore, new regulations governing power battery recycling took effect on April 1, introducing tighter oversight across collection channels, processing stages, and the full product lifecycle. Together, these measures signal tighter timelines and more defined compliance requirements.

Across international markets, the European Union’s New Battery Regulation is phasing in carbon footprint thresholds and mandating digital battery passports, provisions that tie a manufacturer’s carbon footprint directly to market access in the EU. Major automakers, including Volkswagen and BMW, have already established their own carbon neutrality targets and are pushing decarbonization requirements down through their battery supply chains.

With these regulatory forces converging globally, CIBF2026 is positioned to serve as a key venue for advancing the zero-carbon transition. The fair will span the full industrial spectrum: power batteries, energy storage systems, raw materials, advanced manufacturing equipment, and recycling technologies, covering the full battery value chain, from upstream materials to downstream recycling.

As a key industry event, CIBF2026 serves as a venue where industry requirements, manufacturing deployment, and emerging technologies intersect, offering a platform for both technical exchange and international engagement. Leading global battery manufacturers, including CATL, BYD, EVE Energy, Gotion High-tech, and Sunwoda, have confirmed their participation and are expected to present their latest advances in lower-emission manufacturing and lifecycle management.

The exhibition will also highlight green innovations across the entire battery value chain. From low-carbon precursors and recycled materials at the upstream end, to cleaner manufacturing equipment and low-emission processes at the production stage, and extending to high-efficiency dismantling technologies downstream—the event will present a full range of solutions focused on reducing lifecycle emissions, while enabling more direct exchanges of technical know-how between market participants across China and international supply chains.

Spanning materials, manufacturing, and recycling, China’s battery supply chain is increasingly functioning as an integrated system that improves efficiency and reduces emissions. This shift is driven by companies’ responses to both regulatory mandates and changing customer expectations in global markets.

As a leading platform for sustainable battery industry development, CIBF2026 will host a concurrent lineup of high-level forums, including the CIBF2026 Conference on the Frontier Technology of Advanced Batteries, the Conference on Next Generation Battery Technology and Advanced Manufacturing for Electric Aviation, the 6th China International Conference on New Energy Storage Technology and Engineering Application, the Annual Conference of the CIAPS Lithium Iron Phosphate Materials Branch, and the 3rd Battery Passport and Sustainable Development Technology Seminar. These sessions will bring together business leaders, industry experts, and researchers to engage in focused discussions on manufacturing pathways, circular economy models, and carbon footprint management, with an emphasis on practical implementation, standards alignment, and cross-border interoperability.

On the occasion of Earth Day, companies, experts, researchers, and professionals from across the global renewable energy community are invited to gather in Shenzhen for CIBF2026 to align industry efforts toward a lower-emission global supply chain, accelerate the transition to more sustainable energy systems, and deepen cross-border collaboration in real-world applications.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/world-earth-day-2026-highlights-zero-carbon-push-as-cibf2026-prepares-to-gather-global-battery-industry-302750388.html

SOURCE China Industrial Association of Power Sources (CIAPS)

Bored No More Charity Launches “Pet Packs” for Animal Shelters and a New Donor App — Just in Time for National Volunteer Week, Adopt a Shelter Pet Day, and National Rescue Dog Day

PHILADELPHIA, April 22, 2026 /PRNewswire/ — Bored No More charity (www.BoredNoMoreCharity.org), the youth-founded nonprofit led by Philadelphia teen sisters Taylor Brady (17) and Alexis Brady (18), is a 2026 Silver Anvil Finalist in the Silver Anvil Strategic Award for Nonprofits from the Public Relations Society of America (PRSA) — one of the most prestigious honors in the field— while simultaneously expanding its mission to support animal shelters nationwide.

Since its founding in 2023, Bored No More has delivered health and wellness activity packages reaching more than 3,500 hospitalized children and their families. The nonprofit announces two new initiatives: Bored No More Pet Packs, a program that provides enrichment supplies and adoption gear for dogs and cats to animal shelters across the U.S., and the Bored No More WishLink App, a free donor tool that connects supporters directly to Amazon Wishlists for children’s hospitals and animal rescues.

PRSA Silver Anvil Nomination

Bored No More is a 2026 Silver Anvil Finalist in the Community Relations category for Associations and Nonprofit Organizations, recognized for its project: Bored No More: A Vital Teen-Led Health & Wellness Initiative to Improve Pediatric Hospitalization Experiences through Community Outreach. Winners will be announced May 14, 2026, at the 2026 Anvil Awards ceremony in New York City.

“Bored No More Pet Packs”: Helping Shelter Animals Find Their People

Launched in early 2026, Pet Packs grew out of co-founder Taylor Brady’s personal connection to animal rescue — the family adopted their two dogs, Toby and Bear, through a Miami rescue.

“I want other pets to have a more comfortable shelter experience, with every opportunity to get adopted by wonderful families,” said Taylor Brady. “We work directly with shelters to figure out exactly what they need.”

In its first three months, the program has already donated to shelters in Shorter, Alabama; San Francisco, and Los Angeles, California; Miami, Fort Lauderdale, and Palm Beach, Florida; Maui, Hawaii; Hampton Bays and New York City, New York; Philadelphia, Pennsylvania; and Carlisle, South Carolina. Donations have included individual items as well as shareable ones that can be enjoyed repeatedly, including calming donut beds, fun flavored chew toys, “Adopt Me” leashes and leash wraps, cat playpens, scratch posts, interactive wands, joint supplements, and more — supporting many of these 10,000 dogs and cats at these locations.

The response from shelter staff has been enthusiastic. “I am thrilled that these two young community leaders (Taylor and Alexis Brady of Bored No More) have expanded their charitable mission and impact to include animals in need. Support like this goes far beyond the items themselves,” said Nichole Brophy, Operations Manager at Street Tails Animal Rescue in Philadelphia. “It helps our dogs feel more comfortable, build confidence, and be seen — and that’s what ultimately connects them with the right families.”

The Bored No More WishLink App: Connecting Donors to the Causes They Care About

Taylor Brady also personally developed the WishLink App, a free, searchable directory that links donors directly to Amazon Wishlists of pediatric hospitals and animal shelters. It is easy to use, and people can search by name, city, or state — removing the guesswork from giving.

“I wanted to make it as simple as possible for donors to support causes close to their hearts — or close to their homes,” said Taylor. The app is available at Bored No More Charity WishLink and is provided on the Impact section of the Bored No More website.

Timely Observances

  • National Volunteer Week: April 19–25, 2026
  • Adopt a Shelter Pet Day: April 30, 2026
  • National Rescue Dog Day: May 20, 2026

About Bored No More Charity

Founded in 2023 by Philadelphia sisters Taylor Brady (17) and Alexis Brady (18), Bored No More delivers Kids Care activity bags to hospitalized children — filled with Pop Sockets, fidget spinners, mini Etch-A-Sketches, Matchbox cars, coloring books, Crayola crayons, UNO cards, and more — shown to reduce anxiety in pediatric patients. The new Pet Packs program was inspired by the sisters’ own rescue dogs Toby and Bear, and their (non-rescue) hypoallergenic cats Turtle and Oreo.

The charity is supported by AT&T, Drive David (David Auto), Veronica Beard, Kendra Scott, The Do Gooders Philadelphia, Karma For Cara, ILYAN jewelry, artist Jessie Tristan Read, and Charity featured in Forbes, Yahoo! Creators, Main Line Today (“Top Young Innovators”), ABC 6 Philadelphia, and CBSNews.com.

Learn more: www.BoredNoMoreCharity.org & Instagram: @charityborednomore

New APP: Bored No More Charity WishLink

High-Res Images Here:

Interviews with Taylor and Alexis Brady are available upon request. More photos available upon request.

Contact: Allison Weiss Brady/Simplified Media Agency/ 412572@email4pr.com / 305-968-2323

Michele Iapicco/Simplified Media Agency/ 412572@email4pr.com / 210-560-8250

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/philadelphia-teen-sisters-earn-prestigious-prsa-silver-anvil-finalist-while-expanding-charity-to-help-shelter-animals-302749576.html

SOURCE Bored No More charity

Exclusive partnership brings AI-powered camera control, live streaming, and game-day moments into a single platform for sports organizations, teams, and families

CHICAGO, April 22, 2026 /PRNewswire/ — TeamSnap, the #1 youth sports management platform, and XbotGo, a leader in AI-powered sports cameras, today announced an exclusive partnership to redefine live streaming in youth sports. Together, the companies are introducing the first fully integrated, all-in-one live streaming experience, bringing camera control, live video, and game-day moments into TeamSnap ONE.

XbotGo is the leading innovator in AI-powered sports video, making broadcast-quality, automated game capture accessible to every team and family. The partnership brings live streaming into the same app teams already use to manage schedules, communication, and game-day coordination. By combining TeamSnap’s scale and reach with XbotGo’s Falcon AI-powered camera technology, the companies are making it easier for coaches, parents, and organizations to capture, share, and relive the moments that matter most.

“We’re focused on making game day simpler and more connected for the entire youth sports community,” said Peter Frintzilas, CEO of TeamSnap. “Families want an easy way to capture and share the moments that matter. Coaches want less friction on game day. Organizations want technology that fits naturally into how they already run their programs. By partnering exclusively with XbotGo, we’re bringing live streaming into TeamSnap ONE and taking another step toward a more complete season experience.”

Today, streaming in youth sports often means piecing together multiple technologies for team operations, camera setup, live video, and sharing. This fragmented approach creates added complexity on game day and disconnects video from the rest of the team experience.

TeamSnap and XbotGo remove that friction with one connected experience inside TeamSnap ONE. The same app teams use to manage their season now powers camera setup, live streaming, and one-tap highlights. Combined with TeamSnap’s platform, which powers registration, schedules, communication, and game-day coordination, the partnership extends that experience into video, connecting everything from signup to game-day moments in one system.

Powered by XbotGo’s Falcon camera, the experience combines AI-powered tracking, robotic zoom, and high-quality 4K HD video, all built directly into TeamSnap ONE. By integrating advanced camera technology into the platform families and organizations already trust, the partnership makes live streaming a natural part of the season — not a separate workflow on game day.

“As a sports parent myself, I know the struggle of missing a goal while fiddling with a phone. XbotGo was built to make sports video smarter, simpler, and more accessible,” said David Tan, Founder and CEO at XbotGo. “By integrating directly with TeamSnap ONE, we’re bringing that experience directly into the platform sports organizations, teams, and families already rely on every day. This partnership makes it easier to stream every game, capture every moment, and stay connected from anywhere.”

The announcement marks the beginning of a broader evolution in how youth sports communities capture, share, and experience the season. Together, TeamSnap and XbotGo are building a more connected future where team operations, live streaming, and season memories live in one place.

To learn more about the TeamSnap and XbotGo partnership and sign up for our early innovators program, visit https://info.teamsnap.com/xbotgo.html.

About TeamSnap
TeamSnap – the #1 sports management platform – has pioneered the future of youth sports technology for more than 15 years. With 19,000+ sports organizations and more than 30 million parents, players, coaches and administrators across more than 100 different sports and activities, TeamSnap powers the largest and most engaged online community in youth sports. Through TeamSnap, brands have invested more than $20 million in youth sports sponsorships, fueling communities and giving more kids the chance to play.
For more information, visit the TeamSnap website, and follow the company on LinkedIn, Instagram, Facebook and YouTube.

About XbotGo
XbotGo is the consumer AI brand of Blink Tech, Inc., founded by Dr. David Tan — a computer vision expert, hardware innovator, and passionate soccer dad. Driven by the belief that everyone should be able to capture and relive their best sports moments, XbotGo makes pro-level videography easy and accessible for all. With a core team of graduates from globally renowned institutions and veterans from leading tech companies, XbotGo operates in Silicon Valley, Texas, Beijing, Shenzhen, and Suzhou, leveraging global R&D and supply chain advantages to drive innovation worldwide.

Media Contacts:
TeamSnap
Alexandra Shafer
JConnelly for TeamSnap
teamsnap@jconnelly.com 
973-934-5100

XbotGo
Gabriel Roxas
gabrielroxas@xbotgo.com
469-922-3416

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/teamsnap-and-xbotgo-partner-to-redefine-youth-sports-streaming-with-industry-first-fully-integrated-ai-powered-experience-302749882.html

SOURCE TeamSnap

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada1. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

1 Azzarello D and Collins J. Canadian access to hormonal contraceptive drug choices. J Obstet Gynaecol Can 2004; 26: 489-500. DOI: 10.1016/s1701-2163(16)30660-0

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada1. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

1 Azzarello D and Collins J. Canadian access to hormonal contraceptive drug choices. J Obstet Gynaecol Can 2004; 26: 489-500. DOI: 10.1016/s1701-2163(16)30660-0

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada1. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

1 Azzarello D and Collins J. Canadian access to hormonal contraceptive drug choices. J Obstet Gynaecol Can 2004; 26: 489-500. DOI: 10.1016/s1701-2163(16)30660-0

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

 

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

  • Forest area created: ~4,000 acres (approximately 3,000 football fields)
  • Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
  • Oxygen produced: Supporting nearly 320,000 people annually
  • Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

 

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

  • Forest area created: ~4,000 acres (approximately 3,000 football fields)
  • Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
  • Oxygen produced: Supporting nearly 320,000 people annually
  • Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

 

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

  • Forest area created: ~4,000 acres (approximately 3,000 football fields)
  • Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
  • Oxygen produced: Supporting nearly 320,000 people annually
  • Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

The company celebrates a meaningful milestone in its ongoing initiative to make a lasting impact within global communities

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — ServiceForge, the 24/7 live answering and customer service platform built for skilled trades and home service businesses, announces a significant achievement in its ongoing sustainability drive: the company has now planted more than two million trees worldwide, a milestone reached in time for Earth Day 2026.

 

Each month, ServiceForge plants one tree for every employee and every customer. What began as a simple commitment to give back has grown into a meaningful, long-term impact effort, now surpassing a major milestone. This accomplishment reflects the company’s continued dedication to environmental stewardship and community-focused values.

For context, two million trees adds up to:

  • Approximately 4,000 acres of forest
  • Roughly 3,000 football fields
  • Trees sufficient to remove an estimated 44,000 metric tons of CO₂ per year (equivalent of taking 9,500 cars off the road)

“This milestone reflects the kind of work we believe in: steady, intentional and rooted in real impact,” said Jane Blanchard, head of brand and marketing for ServiceForge. “In the skilled trades, success isn’t about quick wins; it’s about the slow, human work of strengthening homes, businesses and communities. Planting trees is a natural extension of that mission. It’s a way for us to contribute to something lasting, something that grows alongside the businesses we serve.”

ServiceForge partners with verified reforestation organizations that plant trees in areas affected by deforestation, wildfires and climate change. Partners include Trees for the Future, Save the Redwoods League and Friends of Pando, ensuring that each tree contributes to restoration efforts where it’s needed most.

“We’re in the business of fixing things,” Blanchard said. “What better way to exemplify that commitment than by planting trees, which clean the air, restore habitats and ultimately make the world a better place.”

For more information about ServiceForge and their Giving Back initiative, visit https://www.serviceforge.com/why-serviceforge/givingback

About ServiceForge
ServiceForge helps home service businesses get found, get booked and get paid with 24/7 human answering, scheduling, lead qualification and payments. By combining smart technology with real human connection, ServiceForge helps service businesses stand out in an increasingly disconnected world, ensuring contractors capture more jobs while delivering exceptional customer service. For more information, visit serviceforge.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/serviceforge-plants-two-million-trees-worldwide-302748866.html

SOURCE ServiceForge

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.